Anne Chun Longo
Directeur Général chez PharmatrophiX, Inc.
Profil
Anne Chun Longo is currently the Chief Executive Officer at PharmatrophiX, Inc. She started this position in 2006.
She completed her undergraduate degree at Stanford University.
Postes actifs de Anne Chun Longo
| Sociétés | Poste | Début |
|---|---|---|
PharmatrophiX, Inc.
 PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Directeur Général | 01/01/2006 |
Formation de Anne Chun Longo
| Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
PharmatrophiX, Inc.
PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
